Aptevo Therapeutics (APVO) Stock: Buy, Sell, or Hold?
APVO - Aptevo Therapeutics Inc
$1.61
0.00 (0.00%)
▲
5d:
-0.62%
30d:
-12.02%
90d:
-61.76%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
11d
Get Alerted When APVO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: APVO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: APVO shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: APVO is currently trading at $1.61, which is considered oversold relative to its 30-day fair value range of $1.67 to $1.86.
Technical Outlook: Technically, APVO is in a strong downtrend. The price is currently testing key support at $1.57. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APVO scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.50 (+1483.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APVO is in a strong downtrend. The price is currently testing key support at $1.57. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: APVO scores 63/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.50 (+1483.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.67 -
$1.86
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (63/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1483.9% below Wall St target ($25.50)
- WARNING: Composite score 52/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.67 -
$1.86
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.57
Resistance Level
$1.97
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.15
Wall Street Target
$25.50
(+1483.9%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: October 24, 2026 1:21 AM ET
Data refreshes hourly during market hours. Next update: 2:21 AM
Data refreshes hourly during market hours. Next update: 2:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APVO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$258 | 61 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 61 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 50 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$72 | 48 HOLD |
